CUMBERLAND PHARMACEUTICALS INC Human Resources Contracts & Agreements
62 Contracts & Agreements
- Bonus & Incentive Agreements (10 contracts)
- Compensation Agreements (1)
- Employment Agreements (51)
- Employment Agreement dated March 7, 2024, effective as of January 1, 2024, by and between John M. Hamm and Cumberland Pharmaceuticals Inc (Filed With SEC on March 13, 2024)
- Employment Agreement dated March 7, 2024, effective as of January 1, 2024, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 13, 2024)
- Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between Todd Anthony and Cumberland Pharmaceuticals Inc (Filed With SEC on March 13, 2024)
- Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between Jim Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 13, 2024)
- Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 13, 2024)
- Amendment Number 3 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan, incorporated herein by reference to Appendix A of the Companys Schedule 14A (File No.:... (Filed With SEC on August 11, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Todd Anthony and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between John M. Hamm and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Jim Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)
- Employment Agreement dated March (Filed With SEC on March 13, 2023)
- Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc., incorporated herein by reference to... (Filed With SEC on March 13, 2023)
- Employment Agreement dated March (Filed With SEC on March 13, 2023)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between (Filed With SEC on March 11, 2022)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)
- Employment Agreement dated March (Filed With SEC on March 12, 2021)
- Employment Agreement dated March (Filed With SEC on March 12, 2021)
- Employment Agreement dated March (Filed With SEC on March 12, 2021)
- Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)
- Amendment Number 2 to the Amended and Restated 2007 Director's Incentive Compensation Plan (Filed With SEC on August 14, 2020)
- Amendment Number 2 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan (Filed With SEC on August 14, 2020)
- Employment Agreement dated March (Filed With SEC on March 20, 2020)
- Employment Agreement dated March (Filed With SEC on March 20, 2020)
- Employment Agreement dated March (Filed With SEC on March 20, 2020)
- Employment Agreement dated March (Filed With SEC on March 20, 2020)
- Employment Agreement dated March (Filed With SEC on March 20, 2020)
- Employment Agreement dated March (Filed With SEC on March 12, 2019)
- Employment Agreement dated March (Filed With SEC on March 12, 2019)
- Employment Agreement dated March (Filed With SEC on March 12, 2019)
- Employment Agreement dated March (Filed With SEC on March 12, 2019)
- Employment Agreement dated March (Filed With SEC on March 12, 2019)
- Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)
- Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Michael P. Bonner and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)
- Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)
- Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)